期刊文献+

p16、CDK_4和Rb在人肝细胞癌中的表达 被引量:7

The expression of p16, CDK_4 and pRb in hepatocellular carcinoams
原文传递
导出
摘要 目的分析p16基因、细胞周期蛋白依赖性激酶(CDK4)和视网膜母细胞瘤基因(Rb)在人肝细胞癌中表达的改变。方法用免疫组织化学方法对40例肝细胞癌和癌分组织作检测。结果肝癌组织中的p16蛋白、CDK4和Rb蛋白的异常表达分别为94.44%(34/36)、40.00%(16/40)和45.71%(16/35)。p16蛋白阴性或弱阳性而pRb呈强阳性者13例(13/34,38.23%),两者的表达呈负相关关系二和Rb均异常者15例(15/34,44.11%),表明Rb表达的调节除p16外,还有其他的途径。CDK4过度表达的14例中大多伴P16的改变(13/14,92.85%),50.00%能影响Rb蛋白的表达,同时伴p16和Rb异常者为46.15%。三者的异常表达与肝癌的恶性程度无相关关系。结论细胞调节因子P16基因、CDK4和Rb的表达异常,均参与肝细胞癌的发生。以p16蛋白表达的改变最为明显。 Objective To make an analysis of the expression of pl6 gene, CDK4 and retinoblastomaprotein(pRb) in human hepatocellular carcinoma(HCC). Methods Application of immunohistochelnistfy to40 cases of HCC and their adjacent liver tissues. Results The abnormal expressions of p16, CDK4 and PRbwere 94.44%(34/36), 40.00%(16/40) and 45.71%(16/35) respectively. Rb protein was strongly stained in 13/34(38.23%) cases lacking or weak staining with p16, which showed a negative relation between the expressions of Rb and p16. The abnormal expressions of both p16 and Rb were 15/34(44.11%) cases, indi-indicating that except p16, there are some other ways to roplate Rb. In 14 cases of CDK4 overexpression,most of them (92.85%) presented p16 aberration, 50.00% of them were observed with pRb abnormalexpression, 46.15% of them were along with the alterations of both p16 and pRb. There was no significant correlation between p16 or CDK4 or pRb abnormal expression and HCC malignant grade. ConclusionThe data show that the aberrant expression of p16, CDK4 and pRb may play a role in the carcinogenesiso f HCC. The chances of p16 expression is prominent.
机构地区 广西肿瘤研究所
出处 《中华肝脏病杂志》 CAS CSCD 1999年第2期94-95,共2页 Chinese Journal of Hepatology
基金 国家自然科学基金!No.39060032
关键词 肝细胞癌 蛋白激酶 P16基因 RB蛋白 Carcinoma, hepatocellular Proteinkinase Genes, p16 Protein Rb
  • 相关文献

参考文献6

二级参考文献2

  • 1萧枫,中华肿瘤杂志,1996年,18卷,73页
  • 2Zhou P,Oncology,1995年,11卷,571页

共引文献27

同被引文献70

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部